NCT00377676 - Safety and Tolerability Study of Cycloset in Treatment of Type 2 Diabetes | Biotech Hunter

Enrollment

3,095

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Cycloset

Usual diabetes therapy plus Cycloset

DRUG

Usual Diabetes Therapy plus placebo

Placebo tablet taken orally once in the morning, beginning with one tablet daily, titrated up by 1 tablet each week to a maximum of 6 tablets daily